Medical Malpractice
The cervix is a part of the female reproductive system. It is a narrow cylinder of tissue that connects the uterus and vagina. Cancer that originates in the cervix is known as cervical cancer.
Cancer is more successfully treated when it is diagnosed at an early stage. This is because cancer treatments are continually improving. When a doctor fails to diagnose or misdiagnoses cervical cancer, valuable time is lost.
That lost time is the center of most cervical cancer misdiagnosis lawsuits. A missed abnormal Pap test, a lost HPV result, a delayed biopsy, a failure to follow up on abnormal bleeding, or a failure to tell a patient that something is wrong can turn a treatable cancer into a life-changing or fatal disease.
This page explains cervical cancer, how it is screened for and diagnosed, how misdiagnosis happens, what makes a cervical cancer lawsuit viable, and how cervical cancer lawsuit settlements and verdicts are valued.
If you or a loved one was the victim of cancer misdiagnosis, our medical malpractice lawyers may be able to help. We are experienced in cancer science and fighting insurance companies to get the best results for our clients. Contact us for a free consultation today by calling 800-553-8082 or filling out our brief online form.
What Is Cervical Cancer?
Cancer is a disease that happens when a genetic mutation causes cells to multiply uncontrollably. When this originates in the cervix, it is called cervical cancer. Almost always, this is caused by a persistent infection with high-risk HPV, or human papillomavirus. Long-lasting infection with high-risk HPV causes virtually all cervical cancers, and HPV 16 and HPV 18 cause about 70 percent of cervical cancers worldwide.
The cervix has two parts, each lined with a different type of cell. The endocervix, or the opening of the uterus, is lined with glandular cells. The exocervix, also known as the ectocervix, is the outer part of the cervix and is lined with squamous cells.
This is important because cervical cancer most often begins in the area where these two types of cells intersect, known as the transformation zone. Additionally, cervical cancer is classified based on which of these two cells become cancerous.
Most of the time, cervical cancer starts as a squamous cell carcinoma, beginning with the squamous cells. Other times, adenocarcinomas begin with the glandular cells. Rarely, the cancer begins in both cells, called an adenosquamous or mixed carcinoma.
The transformation zone is also why screening works. Pap tests and HPV tests are aimed at finding dangerous cell changes before they become invasive cancer. When the system works, the patient gets follow-up care before cancer spreads. When the system fails, that failure can become the basis of a cervical cancer misdiagnosis lawsuit.
Can Cervical Cancer Be Prevented?
Cervical cancer is one of the cancers modern medicine is best equipped to prevent. That is what makes failures in diagnosis so frustrating.
If the cancer is a squamous cell carcinoma, which is most often the case, it is usually connected to persistent high-risk HPV infection. HPV is the most common sexually transmitted infection, and most HPV infections clear on their own. The dangerous cases are the infections that persist for years and cause precancerous changes in cervical cells.
The HPV vaccine can prevent infection with the HPV types that cause most cervical cancers. Gardasil 9, while a controversial drug, is FDA-approved for females and males ages 9 to 45 in the United States and protects against several cancer-causing HPV types, including HPV 16 and 18.
But vaccination does not replace screening. HPV vaccination does not protect against every HPV type that can cause cervical cancer. Vaccinated people who have a cervix should still follow cervical cancer screening recommendations.
Cancer cells in the cervix develop gradually, meaning cervical cancer can often be caught in its precancerous stage. This is when the cells show signs of cancer risk, but are not yet invasive cancer. Not all precancers become cancer. But proactively treating a precancer can prevent invasive cervical cancer from developing.
Unlike many other cancers that affect the female reproductive system, cervical precancers can be detected by Pap tests and HPV testing. This is why a missed abnormal Pap smear, missed HPV result, or failure to refer for colposcopy can be such a serious medical error.
How Common Is Cervical Cancer?
The American Cancer Society estimates that in 2026, about 13,490 new cases of invasive cervical cancer will be diagnosed in the United States and about 4,200 women will die from the disease.
Cervical cancer is most often diagnosed in women between ages 35 and 64, and the average age at diagnosis is around 50. More than 20 percent of cervical cancers are found in women over 65, although these cancers are uncommon in women who had regular screening before age 65.
Cervical cancer used to be one of the most common causes of cancer death for American women. Screening changed that. Cervical cancer death rates have dropped by more than half since the mid-1970s because of prevention and screening.
The lesson is that cervical cancer is not some mystery that doctors cannot screen for, test for, or follow. The medical system knows how to find it early in many patients. A malpractice case often asks why that system failed one woman.
Am I at Risk for Cervical Cancer?
Not having had the HPV vaccine and not getting routine cervical cancer screening are two major risk factors. But risk is broader than that.
Risk factors include persistent high-risk HPV infection, weakened immune system, smoking or secondhand smoke exposure, certain reproductive factors, obesity, and rare DES exposure in the womb.
A patient may be at increased risk if she has HIV/AIDS or another condition that compromises the immune system, smokes, has a history of high-risk HPV, has had abnormal Pap or HPV results, has not been regularly screened, or had prior cervical dysplasia.
Risk factors do not prove malpractice, of course. But they can change what a reasonable doctor should do. A patient with abnormal bleeding and a history of abnormal screening deserves more attention than a patient with no risk factors and normal screening. Doctors do not need to panic. They need to investigate.
What Are the Signs That I May Have Cervical Cancer?
Precancerous or early-stage cervical cancers usually have no symptoms. That is why screening is so important. A woman can feel completely fine and still have dangerous cervical cell changes.
Once cervical cancer begins to grow or spread, symptoms may include vaginal bleeding after sex, bleeding between periods, bleeding after menopause, unusually heavy periods, unusual vaginal discharge, pelvic pain, painful sex, swollen legs, blood in urine, or difficulty going to the bathroom.
A doctor should not dismiss abnormal vaginal bleeding as “just hormones” without doing the work. Sometimes bleeding is caused by fibroids, birth control, infection, perimenopause, pregnancy, trauma, or other noncancer causes. But cervical cancer belongs on the list of conditions that must be ruled out when the symptoms and patient history call for it.
For a cervical cancer attorney reviewing a possible malpractice case, the first question is often simple: what symptoms did the patient report, and what did the provider do in response?
How Is Cervical Cancer Screened For and Diagnosed?
Pap tests are used during routine pelvic examinations to screen for cervical cancer. In a Pap test, or Pap smear, a gynecologist uses a speculum to widen the vaginal opening to collect a cell sample. The cells are then analyzed under a microscope to look for cancer cells or cell changes that can become cancer.
The National Cancer Institute explains that the HPV test checks cervical cells for infection with high-risk HPV types that can cause cervical cancer. The Pap test collects cervical cells so they can be checked for changes caused by HPV that may turn into cervical cancer if untreated. HPV and Pap cotesting uses both tests together.
Abnormalities found during routine pelvic exams and abnormal vaginal bleeding should cause a doctor to suspect cervical cancer and order further tests to confirm or rule out the condition.
Doctors usually can diagnose cervical cancer with a Pap smear combined with a biopsy or the removal of a small piece of tissue. To take a biopsy, medical professionals use a colposcope, a magnifying instrument that allows a closer look at the cervix.
Once cancer is diagnosed, doctors determine its stage. Staging is the process of determining how far the cancer has spread. Doctors may use physical examination, biopsy, X-rays, CT scans, MRI, PET scans, cystoscopy, proctoscopy, or other testing depending on the suspected extent of disease.
Put simply, the stages of cervical cancer run from precancerous changes, to cancer limited to the cervix, to cancer that has spread locally or regionally, to cancer that has spread to distant organs. Treatment options and survival odds change dramatically as the disease advances.
Cervical Cancer Screening Guidelines
Screening guidelines vary slightly among organizations, and they continue to evolve. The general medical principle is stable: regular screening and proper follow-up save lives.
The USPSTF recommends Pap testing every three years for women ages 21 to 29. For women ages 30 to 65, the USPSTF recommends screening every three years with Pap testing alone, every five years with high-risk HPV testing alone, or every five years with HPV/Pap cotesting. .
The American Cancer Society recommends that average-risk women and individuals with a cervix start screening at age 25 with primary HPV testing every five years through age 65, with cotesting or Pap testing as acceptable alternatives when primary HPV testing is not available. ACS updated its guidance in 2025 to recognize self-collected vaginal specimens for HPV testing as an option for cervical cancer screening.
Guidelines are not a shield for careless follow-up. If a test is abnormal, a patient has alarming symptoms, or a provider knows the patient has a high-risk history, the next step is not always routine screening. It may be colposcopy, biopsy, referral to gynecology, repeat testing, imaging, or urgent evaluation.
| Stage of Care | What Should Happen | Malpractice Concern |
|---|---|---|
| Symptoms | Abnormal bleeding, pelvic pain, unusual discharge, or postmenopausal bleeding should be investigated. | The provider dismisses symptoms as benign without exam, testing, referral, or follow-up. |
| Screening | Pap testing, HPV testing, or cotesting should be performed according to guidelines and patient risk. | The patient is not screened, is screened too late, or abnormal history is ignored. |
| Lab Review | Pap and HPV results should be accurately interpreted and entered into the chart. | Abnormal cells are missed, HPV results are not reviewed, or results are filed without action. |
| Communication | The patient should be told about abnormal results and the next step. | No one calls the patient, no referral is made, or abnormal results fall through the cracks. |
| Follow-Up | Colposcopy, biopsy, repeat testing, or gynecologic oncology referral should occur when indicated. | The provider fails to order biopsy, delays referral, or treats symptoms without ruling out cancer. |
| Staging and Treatment | Once cancer is found, staging and treatment should move quickly. | Delay allows the cancer to spread and forces harsher treatment or reduces survival odds. |
How Is Cervical Cancer Treated?
In countries like the United States, cervical cancer is considered highly treatable when found early because there are prevention and early detection opportunities. When cervical cancer is not found in the early stages, sometimes due to misdiagnosis, treatment is more challenging and often less effective.
Cervical cancer treatment includes surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or combinations of these treatments depending on stage, tumor size, spread, and patient factors.
Treatment options depend on where the cancer is located, how far it has spread, and the patient’s goals. Early-stage cancers may be treated with procedures that remove abnormal or cancerous tissue. For women who do not wish to preserve fertility, a hysterectomy, or the removal of the uterus and cervix, may be recommended.
The further the extent of the cancer, the greater the need for more extensive surgery, radiation therapy, chemotherapy, and sometimes targeted therapy or immunotherapy.
Delayed diagnosis can change everything. A woman who might have needed a local procedure or limited surgery may instead need radical hysterectomy, chemotherapy, radiation, lymph node dissection, bladder or bowel procedures, or palliative care. That is why a cervical cancer lawyer focuses on what treatment would have been available if the diagnosis had been timely.
How Deadly Is Cervical Cancer?
The prognosis depends heavily on the stage at diagnosis. The five-year relative survival rate for cervical cancer is 91 percent when the cancer is localized, 62 percent when it is regional, and 20 percent when it is distant. Across all stages combined, the five-year relative survival rate is 68 percent.
Those numbers are not just statistics. They explain the harm in a cervical cancer misdiagnosis case. If the delay moved the patient from a localized cancer to regional or distant cancer, the malpractice may have changed treatment, fertility, survival odds, and the rest of the patient’s life.
What Causes Cervical Cancer Misdiagnosis?
Misdiagnosing cancer is a costly mistake and may constitute malpractice or wrongful death. Any delay in diagnosis subsequently causes a delay in treatment, allowing the cancer to spread unchecked. This could mean that a cancer patient will need more invasive surgeries or have a reduced life expectancy than if she had been diagnosed when she should have been.
Cervical cancer misdiagnosis can happen for many reasons. A doctor may fail to investigate abnormal bleeding. A gynecologist may fail to order a Pap test or HPV test. A primary care doctor may treat symptoms as infection or hormonal bleeding without ruling out cancer. A lab may misread Pap smear results. A medical office may receive abnormal results and never call the patient. A referral may never be made. A biopsy may be delayed.
First, if a woman presents to a healthcare professional with symptoms such as abnormal bleeding, unusual discharge, or pelvic pain, that doctor needs to perform testing or refer the patient for testing when the symptoms and history call for it. The doctor should investigate the patient and ask detailed questions about her history.
Diagnostic errors do not always lie with the doctor. The error may lie with the lab technician who interpreted the Pap smear test results. There may have been an error in communication between the healthcare facility and the laboratory. It is also a problem if the doctor fails to communicate with and inform the patient about what is going on.
Failure to timely diagnose cervical cancer can lead to severe pain and suffering, loss of reproductive organs, premature death, expensive treatment, and a longer recovery.
Is Cervical Cancer Misdiagnosis Medical Malpractice?
Failure to recognize and diagnose cervical cancer can lead to severe pain and suffering, the loss of reproductive organs, premature death, expensive treatment, and an increased time to recovery. The plaintiff may be able to recover these consequences in the form of monetary damages in a medical malpractice lawsuit or wrongful death lawsuit.
This is not necessarily malpractice if a patient is treated for cancer and the treatment is unsuccessful. Doctors are not liable for every bad outcome. For malpractice to have occurred, there must have been an oversight or error in diagnosis or treatment that falls below the standard of medical care.
In a cervical cancer misdiagnosis lawsuit, the patient usually must prove that a healthcare provider violated the standard of care, and that the violation caused harm. Common malpractice theories include failing to recognize symptoms, failing to order Pap or HPV testing, misreading a Pap smear or biopsy, failing to communicate abnormal results, failing to refer for colposcopy or biopsy, or failing to timely stage and treat cancer.
The most difficult issue is often causation. The cervical cancer attorney must show what would have happened with a timely diagnosis. Would the cancer have been found at a lower stage? Would less invasive treatment have been available? Would survival odds have been better? Would the patient have avoided radical surgery, infertility, radiation, chemotherapy, or death?
What You Need to Prove in a Cervical Cancer Lawsuit
A cervical cancer lawsuit usually turns on four questions.
First, what did the patient report? The symptoms, screening history, Pap results, HPV results, prior abnormal tests, age, risk factors, and medical visits create the timeline.
Second, what should the doctor, lab, or facility have done? This is the standard-of-care question. The answer may come from gynecology experts, pathology experts, oncology experts, screening guidelines, office policies, and lab protocols.
Third, how long was the delay? A short delay may not change the outcome. A long delay can allow cancer to progress from precancerous disease to invasive disease, or from localized disease to metastatic disease.
Fourth, what harm did the delay cause? The damages may include more extensive surgery, hysterectomy, infertility, chemotherapy, radiation, pain, lost income, loss of life expectancy, emotional suffering, loss of chance, or wrongful death.
Chart: Evidence in a Cervical Cancer Misdiagnosis Lawsuit
| Evidence | What They Show | What It Can Prove |
|---|---|---|
| Pap and HPV Results | They show whether abnormal cells or high-risk HPV were present earlier. | Missed warning signs, lab error, and failure to follow up. |
| Office Notes | They show symptoms, complaints, exam findings, and what the doctor knew. | Abnormal bleeding, pelvic pain, discharge, and whether the provider investigated. |
| Biopsy and Pathology | Pathology records identify precancer, invasive cancer, and tumor type. | Whether the diagnosis was missed or delayed and whether samples were misread. |
| Communication Records | Phone logs, portal messages, letters, and referral records show whether the patient was told. | Failure to notify, failure to refer, and lost follow-up. |
| Staging and Oncology Records | These records show how advanced the cancer was when finally diagnosed. | Progression, treatment burden, and survival impact. |
| Expert Review | Gynecology, pathology, oncology, and life expectancy experts explain the medical consequences. | Standard of care, causation, damages, and what earlier care would have changed. |
Cervical Cancer Lawsuit Settlements and Case Value
Cervical cancer lawsuit settlements can be substantial because a delayed diagnosis will change the patient’s entire medical future. The value depends on the length of delay, stage progression, lost treatment options, fertility loss, need for hysterectomy, chemotherapy, radiation, recurrence risk, life expectancy, and whether the patient died.
The highest-value cases usually involve a clear missed opportunity. For example, an abnormal Pap test was in the chart, but no one told the patient. Or a patient reported abnormal bleeding for months, but no biopsy was ordered. Or a lab misread cancer cells as normal. Or the doctor documented high-risk HPV but never sent the patient for colposcopy.
A lower-value or no-value case is where there is negligence, but it is hard to prove that the delay changed the treatment or prognosis. Medical malpractice is not just about proving a mistake. The cervical cancer lawyer must prove that the mistake caused harm.
Economic damages may include medical expenses, future treatment, lost wages, loss of earning capacity, fertility treatment, counseling, and end-of-life care. Non-economic damages may include pain, suffering, emotional distress, loss of fertility, loss of normal life, disfigurement, sexual dysfunction, and loss of companionship. In a wrongful death case, the claim may include funeral expenses and damages to surviving family members under state law.
Sample Cervical Cancer Settlement Amounts and Jury Payouts
Below are examples of cervical cancer misdiagnosis and failure-to-diagnose verdicts and settlements. These cases are not predictions. They show how juries and defendants evaluate cervical cancer lawsuit settlements when delayed diagnosis changes treatment, survival, or quality of life.
$49,000,000 Verdict in Connecticut in 2026
A Stamford jury awarded $49 million to a woman whose gynecologist allegedly failed to follow standard protocols for monitoring high-risk HPV, allowing cervical cancer to progress to a late-stage, terminal disease.
This is the kind of case that shows the enormous value of missed follow-up. The core claim was not that cervical cancer is always curable. The claim was that high-risk HPV created a known warning sign and that failure to monitor let the disease advance.
$7,668,363 Verdict in Oklahoma in 2021
An adult woman underwent a radical hysterectomy after an alleged delayed diagnosis of cervical cancer while under the care of Mercy Clinic Oklahoma Communities and GenPath, also known as BioReference Laboratories. The plaintiff alleged that her Pap smear was incorrectly read and reported as a low-grade squamous intraepithelial lesion, or LSIL, when it should have been reported as a high-grade squamous intraepithelial lesion, or HSIL. She also alleged that the Mercy providers failed to inform her of abnormal findings, delaying diagnosis and treatment.
The defendants denied liability. GenPath argued that it reported a low-grade lesion to Mercy and that Mercy staff admitted the plaintiff was not notified of the abnormal finding until January 2017, more than a year after the October 2015 Pap smear. The jury awarded $7.5 million in pain and suffering, plus $168,363 in interest, for a total of $7,668,363. The jury assigned 50 percent fault to Mercy Clinic, 35 percent to GenPath, and 15 percent comparative negligence to the plaintiff. The court later entered judgment against Mercy for $3,834,181.62, and GenPath settled after the verdict.
This is a strong cervical cancer misdiagnosis lawsuit example because it involves two recurring failure points: alleged misreading of cervical screening results and failure to notify the patient of abnormal findings. The reduced judgment also makes the result more complicated than the headline number. The jury valued the harm at more than $7.6 million, but comparative fault, fault allocation, and post-verdict settlement issues changed the final recovery picture.
$9,680,000 Verdict in Pennsylvania in 2019
The plaintiff, a minor, visited several doctors over two years with complaints of irregular periods. She underwent an ultrasound that revealed a cervical mass. Doctors failed to notify her family and failed to refer her for treatment. Two months later, she was brought to the emergency room, where staff notified her family of the mass. One month later, she was diagnosed with Stage III cervical cancer and underwent radical, disabling surgery.
Her family sued the doctors for failing to diagnose the cancer promptly. A jury awarded the plaintiff and her family $9,680,000. This case is a stark example of how failure to communicate an abnormal result can produce catastrophic harm.
$7,688,000 Verdict in Oklahoma in 2024
The plaintiff alleged that the defendants delayed the diagnosis of cervical cancer by misinterpreting Pap smear results as normal when the results were abnormal for cancer. The delay allegedly allowed the cancer to progress before the correct diagnosis was made. Reported case summary.
This is a classic cervical cancer misdiagnosis lawsuit theory. Pap smear screening only works when the sample is read correctly, the result is communicated, and abnormal findings trigger follow-up.
$1,900,000 Settlement in California in 2017
The plaintiff was a 39-year-old woman who underwent a Pap smear and HPV test that showed abnormal results. Her gynecologist recommended a colposcopy, but the abnormal test results were not communicated. Less than a year later, she returned with bleeding and abdominal cramps and was prescribed birth control pills. The next year, she was told she had fibroids and that steroid use caused the bleeding. During fibroid surgery, she was found to have Stage IV cervical cancer. She died the following year.
Her husband alleged delayed cervical cancer diagnosis and claimed the pathologist misinterpreted tissue samples. The case settled for $1,900,000. Why the big settlement? Abnormal Pap and HPV results demand follow-up, not reassurance without proof.
$1,000,000 Settlement in Massachusetts in 2019
The plaintiff went to her primary care doctor complaining of vaginal bleeding between periods. She told the physician that she had been bleeding like this for over a year. The plaintiff alleged that even though her Pap test was abnormal, the physician failed to note the result or notify her. She was diagnosed a year later at the hospital with metastatic cancer.
The defendant denied liability but settled before trial for $1 million. This is a good example of how abnormal bleeding and abnormal Pap results can combine to create a powerful failure-to-diagnose claim.
$725,000 Settlement in New Jersey
A woman’s Pap smear was reportedly interpreted as mildly abnormal by the cytology laboratory, followed by later testing that was read as normal. The claim alleged that proper testing and follow-up would have led to earlier detection of cervical cancer. Reported settlement summary.
This settlement is lower than some later verdicts, but it still shows the recurring claim pattern: abnormal cervical screening, poor follow-up, and cancer that should have been caught sooner.
Why Cervical Cancer Misdiagnosis Cases Can Have High Value
A cervical cancer misdiagnosis case can be of high value because the harm is often permanent. The patient may lose fertility, undergo radical hysterectomy, endure chemotherapy and radiation, suffer sexual dysfunction, experience early menopause, or face a terminal diagnosis that could have been avoided with timely care.
The value rises when the delay clearly changes the stage of cancer. A missed precancer is different from a missed Stage I cancer. A missed Stage I cancer that becomes Stage III or Stage IV is different again. The longer the delay and the greater the stage progression, the stronger the damages case becomes.
The defense will usually argue that the outcome would have been the same even with an earlier diagnosis. That is why cervical cancer lawyers focus so heavily on medical timelines, pathology, staging, tumor growth, screening history, and expert oncology opinions.
Common mistakes include:
- Failure to order Pap or HPV testing
- Failure to follow up on abnormal results
- Failure to refer for colposcopy or biopsy
- Misreading Pap smear or biopsy samples
- Dismissing abnormal bleeding
- Failing to tell the patient about the dangerous results
Damages may include:
- Medical expenses and future treatment
- Lost income and loss of earning capacity
- Pain, suffering, and emotional distress
- Loss of fertility and sexual function
- Loss of life expectancy
- Wrongful death damages when the patient dies
Hiring a Lawyer for Your Claim
For a free consultation of your potential medical malpractice case, call our cervical cancer lawyers at 800-553-8082 or fill out our brief online form.
The first step is getting the records. Pap results, HPV results, pathology slides, office notes, referral records, and oncology records can tell us whether your cervical cancer should have been diagnosed earlier.